May 23, 2024
37:25
For every 25 shares held, investors received 37. The price per share adjusted from $41.56 to $28.08.
The split itself did not change the total investment value.
Enwei Pharmaceutical Co., Ltd. Class A (SZSE:301331) operates in the Pharmaceuticals: major industry.
Enwei Pharmaceutical Co., Ltd. Class A company overviewEnwei Pharmaceutical Co., Ltd. Class A's most recent stock split was on May 23, 2024. It was a 37-for-25 forward split, so shareholders received 37 shares for every 25 they held.
Enwei Pharmaceutical Co., Ltd. Class A has split its stock once. This history records one forward split, on May 23, 2024.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Enwei Pharmaceutical Co., Ltd. Class A's 37-for-25 split on May 23, 2024, every 25 shares became 37 shares.
Enwei Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on May 23, 2024, 2 years ago. Companies announce splits in advance, and any new SZSE:301331 split will appear on this page.
Already premium?